State of Knowledge on the Metabolic Syndrome and NASH in the Ivorian Population: Case of People Attending the Diabetology Endocrinology Service of the University Hospital Center (CHU) of Yopougon (Abidjan, Côte d’Ivoire)
- 1 Laboratory of Biology and Health: Biosciences Training and Research Unit, Félix Houphouët-Boigny University of Abidjan, Abidjan, Côte d’Ivoire
- 2 Laboratory of Biology and Health: Biosciences Training and Research Unit, Félix Houphouët-Boigny University of Abidjan, Abidjan, Côte d’Ivoire
- 3 Laboratory of Biology and Health: Biosciences Training and Research Unit, Félix Houphouët-Boigny University of Abidjan, Abidjan, Côte d’Ivoire
- 4 Department of Endocrinology and Diabetes, University Hospital Center (CHU) of Yopougon, Abidjan, Côte d’Ivoire
- 5 Department of Endocrinology and Diabetes, University Hospital Center (CHU) of Yopougon, Abidjan, Côte d’Ivoire
- 6 Laboratory of Biology and Health: Biosciences Training and Research Unit, Félix Houphouët-Boigny University of Abidjan, Abidjan, Côte d’Ivoire
Abstract
Non-alcoholic hepatic steatosis (NASH), characterized by an excessive accumulation of lipids in the liver, is strongly associated with Metabolic Syndrome, which groups together a constellation of cardiovascular risk factors that make it an emerging public health problem on a global scale. The objective of this study was to review the state of knowledge on Metabolic Syndrome and NASH in the Ivorian population. It was a retrospective study conducted over a period of 2 months at the Diabetes Endocrinology Department of the University Hospital Centre (CHU) of Yopougon. It included all patients of any age and sex who were hospitalized or received consultation. The criteria of the Metabolic Syndrome defined by the International Diabetes Federation (IDF) were used to define and calculate the prevalence of the Metabolic Syndrome. Our study found a prevalence of 18.66% of Metabolic Syndrome according to the IDF criteria and a prevalence of 3.33% of NASH in a population of 150 patients hospitalized or received in consultation. There was a predominance of women and older subjects, so the current level of knowledge about Metabolic Syndrome and NASH was low in our study population with only 12%. Indeed, patients over 50 years of age were at higher risk of developing Metabolic Syndrome and NASH. Apart from hyperglycemia, abdominal obesity and arterial hypertension were the most common criteria. Finally, age and body mass index (BMI) were significantly associated with the presence of metabolic syndrome and non-alcoholic fatty liver disease (NASH). However, the awareness of the population, the respect of food hygiene and the implementation of recommended strategies are essential elements in the eradication of these different pathologies.
- Caroline, R. (2007) Stéatohépatite et adaptations métaboliques: Effets d’un régime enrichi en lipides saturés, ou carencé en choline et méthionine, sur la bioénergétique et le métabolisme hépatique de rat. Ph.D. Thesis, Université Claude Bernard Lyon 1, Lyon.
- Anstee, Q.M., Targher, G. and Day, C.P. (2013) Progression of NAFLD to Diabetes Mellitus, Cardiovascular Disease or Cirrhosis. Nature Reviews Gastroenterology and Hepatology, 10, 330-344. https://doi.org/10.1038/nrgastro.2013.41
- Balkau, B., Vernay, M., Mhamdi, L., Novak, M., Arondel, D., Vol, S., Tichet, J. and Eschwège, E. (2003) The Incidence and Persistence of the NCEP (National Cholesterol Education Programm) Metabolic Syndrome. Diabetes & Metabolism, 29, 526-532. https://doi.org/10.1016/S1262-3636(07)70067-8
- Gamila, S. and Dallongeville, J. (2003) Epidémiologie du syndrome métabolique en France. Medical Nutrition, 39, 89-94.
- Ford, E.S., Giles, W. and Dietz, W.H. (2002) Prevalence of the Metabolic Syndrome among US Adults: Finding from the Thirdnational Health and Nutrition Examination Survey. Journal of the American Medical Association (JAMA), 287, 356-359. https://doi.org/10.1001/jama.287.3.356
- Coste, M. (2006) Prévalence du syndrome métabolique chez les patients de 30 à 64 ans durant un mois de consultation. Ph.D. Thesis, Université Claude Bernard Lyon 1, Lyon, 19.
- Azizi, F, Salehi, P., Etemadi, A., and Zahedi-ASL, S. (2001) Prevalence of Metabolic Syndrome in a Urban Population: Tehran Lipid and Glucose Study. Endocrine Research Center, Tehran, 143.
- Alexander, C.M., Landsman, P.B., Teutsch, S.M. and Haffner, S.M. (2003) NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heartdisease among NHANES III Participants Age 50 Years and Older. Diabetes, 52, 1210-1214. https://doi.org/10.2337/diabetes.52.5.1210
- Ginsberg, H.N. and Stalenhoef, A.F. (2003) The Metabolic Syndrome: Targeting Dyslipidaemia to Reduce Coronary Risk. Cardiovascular Risk, 10, 121-128. https://doi.org/10.1177/174182670301000207
- Ilanne-Parikka, P., Eriksson, J.G. and Lindstrom, J. (2004) Prevalence of the Metabolic Syndrome and Its Components: Findings from a Finnish General Population Sample and the Diabetes Prevention Study Cohort. Diabetes Care, 27, 2135-2140. https://doi.org/10.2337/diacare.27.9.2135
- Tichet, J. and Vol, S. (2005) Fréquence du syndrome métabolique et de ses anomalies selon les définitions du NCEP-ATP III, De l’IDF et de l’AHA/NHLBI chez 19126 hommes et 18874 femmes agés de 20 à 74 ans de 2002 à 2004. Diabètes care, 28, 1769-1778.